— Know what they know.
Not Investment Advice
Also trades as: DEMANT.CO (CPH) · $vol 15M · WILYY (OTC) · $vol 0M

WILLF OTC

Demant A/S
1W: +0.0% 1M: +3.5% 3M: +13.2% YTD: +34.6% 1Y: +30.2% 3Y: +12.9% 5Y: -7.2%
$45.55
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Buy · Power 69 · $9.6B mcap · 84M float · 0.0003% daily turnover · Short 75% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$9.6B
52W Range28.08-45.55
Volume100
Avg Volume264
Beta0.76
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSøren Nielsen
Employees26,704
SectorHealthcare
IndustryMedical - Devices
IPO Date2012-08-13
Websitedemant.com
Kongebakken 9
Smørum, ZE 2765
DK
45 39 17 73 00
About Demant A/S

Demant A/S is a leading global enterprise specializing in the fields of hearing healthcare and audio technology. The company's primary focus is on the research, production, and sale of advanced solutions and devices aimed at enhancing individuals' hearing abilities across Europe, North America, the Pacific region, Asia, and other international territories. Its operations are strategically divided into two core segments: Hearing Healthcare and Communications. The Hearing Healthcare division provides a comprehensive suite of offerings, including hearing implants, assistive listening devices, audiological care services, and diagnostic equipment. Conversely, the Communications segment is dedicated to furnishing high-quality headsets for collaborative professional environments and the competitive gaming market, distributed under its EPOS brand. Originally established in 1904, the organization was previously known as William Demant Holding A/S, officially adopting its current name, Demant A/S, in March 2019. The corporate headquarters for Demant A/S are located in Smørum, Denmark.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms